Stifel Nicolaus Reaffirms Their Buy Rating on Zymeworks (ZYME)
Zymeworks Price Target Maintained With a $10.00/Share by HC Wainwright & Co.
Zymeworks Price Target Maintained With a $10.00/Share by HC Wainwright & Co.
HC Wainwright & Co. Reiterates Neutral on Zymeworks, Maintains $10 Price Target
HC Wainwright & Co. analyst Robert Burns reiterates Zymeworks (NASDAQ:ZYME) with a Neutral and maintains $10 price target.
Zymeworks Price Target Cut to $16.00/Share From $17.00 by Citigroup
Zymeworks Price Target Cut to $16.00/Share From $17.00 by Citigroup
Citi: Maintains the Zymeworks (ZYME.US) rating, adjusted from buy to buy rating, and adjusted the target price from $17.00 to $16.00.
Citi: Maintains the Zymeworks (ZYME.US) rating, adjusted from buy to buy rating, and adjusted the target price from $17.00 to $16.00.
Zymeworks Is Maintained at Overweight by Wells Fargo
Zymeworks Is Maintained at Overweight by Wells Fargo
Wells Fargo Maintains Overweight on Zymeworks, Lowers Price Target to $12
Wells Fargo analyst Derek Archila maintains Zymeworks (NASDAQ:ZYME) with a Overweight and lowers the price target from $14 to $12.
Zymeworks Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/03/2024 33.33% Wells Fargo $14 → $12 Maintains Overweight 03/12/2024 55.56% Wells Fargo $12 → $14 Maint
Zymeworks Inc. (NYSE:ZYME) Q1 2024 Earnings Call Transcript
Here's Why We're Not Too Worried About Zymeworks' (NASDAQ:ZYME) Cash Burn Situation
There's no doubt that money can be made by owning shares of unprofitable businesses. For example, biotech and mining exploration companies often lose money for years before finding success with a ne
Earnings Call Summary | Zymeworks(ZYME.US) Q1 2024 Earnings Conference
The following is a summary of the Zymeworks Inc. (ZYME) Q1 2024 Earnings Call Transcript:Financial Performance:Zymeworks reported a net loss of $31.7 million, or a loss of $0.42 per diluted share, for
Buy Rating Affirmed for Zymeworks on Strong Pipeline and Upcoming Catalysts
Zymeworks Inc (ZYME) (Q1 2024) Earnings Call Transcript Highlights: Navigating Challenges and ...
Zymeworks Inc. (ZYME) Q1 2024 Earnings Call Transcript
Zymeworks Inc. (ZYME) Q1 2024 Earnings Call Transcript
Zymeworks Files Automatic Mixed Securities Shelf
Zymeworks Touts Financial Health and R&D Progress
Zymeworks Q1 2024 GAAP EPS $(0.42) Misses $(0.29) Estimate, Sales $10.030M Miss $17.431M Estimate
Zymeworks (NYSE:ZYME) reported quarterly losses of $(0.42) per share which missed the analyst consensus estimate of $(0.29) by 44.83 percent. This is a 13.51 percent decrease over losses of $(0.37) pe
Zymeworks Inc Stresses Transparency in Investor Communications
Zymeworks 1Q Loss/Shr 42c >ZYME
Zymeworks 1Q Loss/Shr 42c >ZYME
Press Release: Zymeworks Provides Corporate Update and Reports First Quarter 2024 Financial Results
Zymeworks Provides Corporate Update and Reports First Quarter 2024 Financial Results -- Reported $420.5 million in cash resources as of March 31, 2024, which when combined with certain antic
No Data